Palliative and end of life care in idiopathic pulmonary fibrosis
Evidence & Practice    

Palliative and end of life care in idiopathic pulmonary fibrosis

Karen Newell Respiratory clinical nurse specialist, Merton cardio-respiratory team, Central London Community Healthcare NHS Trust, Morden, London, England
Kim Smith End of life care clinical nurse specialist, Merton End of Life Care Team, Central London Community Healthcare NHS Trust, London, England
Anne-Marie Russell Clinical research fellow, National Heart and Lung Institute, Imperial College London, England

Idiopathic pulmonary fibrosis is a life-limiting interstitial lung disease. We do not know what causes it and there is no cure. People experience debilitating symptoms and delays before a diagnosis is confirmed are not uncommon. Palliative and end of life care for these patients is of variable quality. This article introduces and discusses the complexities of recognition, treatment and management of idiopathic pulmonary fibrosis, emphasising the importance of the primary care and community nurse roles. The implications for nursing practice in managing this group of people to live well and to die well will be explored.

Primary Health Care. 28, 4,27-35. doi: 10.7748/phc.2018.e1387

Correspondence

karennewell@nhs.net

Peer review

This article has been subject to double blind peer review

Conflict of interest

None declared

This article has been subject to external double-blind review and checked for plagiarism using automated software

Permission

To reuse this article or for information about reprints and permissions, please contact permissions@rcni.com

Write for us

For information about writing for RCNi journals, contact writeforus@rcni.com